Effects of installing a volatile organic compound-removal filter in a clinical embryology laboratory on embryo development

Article information

Korean J Fertil Steril. 2026;.cerm.2026.09369
Publication date (electronic) : 2026 October 7
doi : https://doi.org/10.5653/cerm.2026.09369
1Advanced Reproductive Medicine Center, Kyoto University Hospital, Kyoto, Japan
2Department of Obstetrics and Gynecology, Graduate School of Medicine, Kyoto University, Kyoto, Japan
3Department of Obstetrics and Gynecology, Medical Research Institute Kitano Hospital, PIIF Tazuke-kofukai, Osaka, Japan
Corresponding author: Yusuke Sagae Department of Obstetrics and Gynecology, Graduate School of Medicine, Kyoto University, 54 Shogoin Kawahara-cho, Sakyo, Kyoto 606-8507, Japan Tel: +81-75-751-3269 Fax: +81-75-761-3967 E-mail: ysat1983@kuhp.kyoto-u.ac.jp
*This study was conducted under a joint research agreement with Daikin Industries, Ltd., and was supported by research funding from the company. The authors declare no other potential conflicts of interest.
Received 2026 March 6; Revised 2026 May 14; Accepted 2026 May 22.

Abstract

Objective

Improving embryo quality is essential for increasing pregnancy and live birth rates in assisted reproductive technology (ART). The culture environment strongly influences embryo quality, and air quality is one of its key components. Volatile organic compounds (VOCs) present in clinical embryology laboratories and incubators have been suggested to adversely affect gametes and embryos. This study examined whether installing a VOC-removal filter in a clinical embryology laboratory affected fertilization rate, cleavage rate, blastocyst formation rate, and good-quality blastocyst rate.

Methods

A VOC-removal filter was installed in the clinical embryology laboratory to reduce ambient VOC concentrations. Embryological outcomes before and after filter installation were compared in both in vitro fertilization and intracytoplasmic sperm injection (ICSI) cycles. The evaluated outcomes were fertilization rate, cleavage rate, blastocyst formation rate, and good-quality blastocyst rate.

Results

VOC concentrations decreased after filter installation; however, blastocyst formation rates did not differ significantly between the pre-installation and post-installation periods. In analyses restricted to ICSI cycles, the proportion of good-quality blastocysts was significantly higher after filter installation than before installation (p=0.0069).

Conclusion

These findings suggest that VOCs in the clinical embryology laboratory may adversely affect embryo quality, particularly in ICSI cycles, which involve relatively prolonged laboratory handling. Management of VOC concentrations may therefore be an important component of efforts to improve embryo culture conditions in ART.

Introduction

Embryo quality in assisted reproductive technology (ART) is a major determinant of pregnancy and live birth rates after embryo transfer [1,2]. It is also highly dependent on the culture environment, which includes culture media, temperature, light exposure, and air quality. Because human gametes and embryos are sensitive to these conditions, environmental factors can substantially influence fertilization and subsequent embryo development [3-9].

Among these environmental factors, air quality within the clinical embryology laboratory and incubators is an important component of embryo culture. Laboratory air contains various substances that may influence culture conditions, including volatile organic compounds (VOCs). VOCs can originate from outdoor sources, such as exhaust emissions and seasonal pollutants, as well as from indoor sources, including building materials, refrigerants, synthetic organic materials such as plastics, and disinfectants such as ethanol. VOCs may also react with ozone to generate particulate matter and other potentially harmful byproducts [10]. Because these compounds can dissolve into culture media, VOC contamination in the laboratory environment may adversely affect embryo development [11-13].

The present study investigated whether installing a VOC-removal filter in a clinical embryology laboratory affected fertilization and embryo development after in vitro fertilization (IVF) and intracytoplasmic sperm injection (ICSI).

Methods

1. Study design

This study evaluated changes in VOC concentrations in the clinical embryology laboratory before and after installation of a VOC-removal filter. It also examined whether these changes were associated with differences in fertilization and embryo development after IVF and ICSI. The primary outcome was blastocyst formation rate. Secondary outcomes were fertilization rate, cleavage rate, and good-quality blastocyst rate.

At our institution, approximately 1,200 morphologically normal oocytes, defined as mature metaphase II (MII) oocytes, are available annually for IVF and ICSI, and the blastocyst formation rate before VOC-filter installation was approximately 20%. Assuming that filter installation would increase the blastocyst formation rate to 25%, the required sample size was initially calculated using G*Power version 3.1 (Heinrich Heine University) with a 1:1 allocation ratio, a significance level (α) of 0.05, and statistical power of 0.80. This calculation indicated that 862 oocytes would be required in each group. However, because the filter could be installed for only 6 months under the terms of the contract, as described in the VOC-removal procedure, the allocation ratio was adjusted to 2:1 for the pre-installation and post-installation periods. On this basis, the planned sample sizes were 1,281 morphologically normal oocytes for the pre-installation period and 640 for the post-installation period.

The post-installation period was defined as July 1, 2022, to December 31, 2022, and the pre-installation period was defined as June 1, 2021, to June 30, 2022. Patients who provided informed consent and underwent IVF or ICSI during these periods were included in the analysis. Ovarian stimulation protocols included gonadotropin-releasing hormone (GnRH) agonist short and long protocols, GnRH antagonist protocols, and a small number of natural cycles. Ovarian stimulation was generally initiated on days 2–3 of the menstrual cycle using human menopausal gonadotropin or recombinant follicle-stimulating hormone at 150 to 300 IU/day, with dose adjustment according to ovarian response. In antagonist cycles, a GnRH antagonist was introduced when the leading follicle reached approximately 14 to 15 mm in diameter. In long protocols, a GnRH agonist was initiated during the mid-luteal phase of the preceding cycle for pituitary downregulation, whereas in short protocols, a GnRH agonist was initiated during the early follicular phase. Final oocyte maturation was triggered when at least one leading follicle reached ≥18 mm in diameter. No specific exclusion criteria were applied, and preimplantation genetic testing for aneuploidy and testicular sperm extraction cycles were included. No oocyte donation cycles were performed during the study period. Baseline patient characteristics, including maternal age, body mass index (BMI), antral follicle count (AFC), and basal hormone levels, are summarized in Table 1. Detailed infertility etiologies are summarized in Supplementary Table 1. This study was conducted and reported in accordance with the Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) guidelines.

Baseline patient characteristics in the overall analysis, IVF cycle, and ICSI cycle

2. Oocyte retrieval and preincubation

During oocyte retrieval, cumulus–oocyte complexes (COCs) were temporarily stored in hydroxyethyl piperazine ethane sulfonicacid (HEPES)-buffered medium (Quinn’s advantage medium with HEPES; SAGE) supplemented with 10% serum protein substitute (SPS; Quinn’s Advantage Serum Protein Substitute; SAGE). The COCs were then transferred to fertilization medium (Quinn’s advantage fertilization [human tubal fluid] medium; SAGE) supplemented with 10% SPS. They were preincubated for 3 to 6 hours at 37 °C in an incubator (APM-300; Astec Co., Ltd.) under 5% CO₂ and 5% O₂ until insemination for IVF or denudation for ICSI.

3. IVF and ICSI procedures

For IVF, sperm concentration was adjusted to 1.0×10⁵/mL, and insemination was performed according to standard protocols. For ICSI, denudation was performed using hyaluronidase (80 IU/mL; SAGE), and only mature MII oocytes were selected for injection. During sperm injection, each oocyte was positioned with the first polar body oriented at either the 6 or 12 o’clock position.

4. Fertilization assessment

Fertilization was assessed 16 to 18 hours after IVF or ICSI. Oocytes with two pronuclei were classified as normally fertilized. Fertilization rate was calculated by dividing the number of fertilized oocytes by the number of morphologically normal oocytes.

5. Cleavage rate

Embryos that underwent cleavage after fertilization assessment were classified as cleaved embryos. Cleavage rate was calculated by dividing the number of cleaved embryos by the number of morphologically normal oocytes.

6. Blastocyst formation rate

The day of oocyte retrieval was defined as day 0. Embryos that reached the blastocyst stage by day 6 of culture were classified as blastocysts. Blastocyst formation rate was calculated by dividing the number of blastocysts by the number of morphologically normal oocytes.

7. Good-quality blastocyst rate

Blastocysts that developed by day 6 were evaluated using the Gardner grading system [14]. Blastocysts with an expansion stage of ≥3 were included in the evaluation. Good-quality blastocysts were defined according to inner cell mass (ICM) and trophectoderm (TE) grades of ≥BB. Blastocysts graded as BC, CB, or CC were classified as poor-quality blastocysts. Expansion stage was not included in the embryo-quality assessment because it may be influenced by developmental timing. Blastocyst grading was performed independently by at least two experienced embryologists. Good-quality blastocyst rate was calculated by dividing the number of good-quality blastocysts by the number of morphologically normal oocytes.

8. Embryo culture

Each well of a 12-well culture dish (Culture Dish 35 mm Time Lapse, REF: 113031TL; Birr) was filled with 20 µL of single-step culture medium (Continuous Single Culture–NX Complete [CSCM-NXC]; FUJIFILM) and overlaid with paraffin oil (Oil for Tissue Culture; SAGE). IVF embryos were transferred to culture dishes after fertilization assessment, whereas ICSI embryos were transferred immediately after microinjection. All embryos were cultured for 6 days in a time-lapse incubator (CCM-iBIS; Astec Co., Ltd.) at 37 °C under an atmosphere of 5% CO₂ and 5% O₂. Blastocysts were assessed manually according to the Gardner classification, and no time-lapse scoring systems, such as KIDScore, were used.

9. VOC-removal procedure

The VOC-removal filter system was installed in the clinical embryology laboratory from July 1, 2022, to December 31, 2022. The system consisted of an organic gas-removal filter (Pure Chemics G, model ACGL-Z-E25; Nippon Muki Co., Ltd.) integrated into a partition-type fan filter unit (model PHW-0171-PS-GO; dimensions, 880×1,415×95 mm; Nippon Muki Co., Ltd.). The unit was positioned near the center of the laboratory. The system operated in circulating air-treatment mode, and ventilation was adjusted to achieve more than five air exchanges per hour. Ambient VOC concentrations in the laboratory were measured before filter installation and 3 months after installation. VOC concentrations inside the incubators were not directly measured.

10. Statistical analysis

Statistical analyses were performed using JMP Pro version 17 (SAS Institute Inc.). A p-value <0.05 was considered statistically significant. Maternal age at oocyte retrieval was analyzed using the Student’s t-test. BMI, AFC, basal follicle-stimulating hormone levels, and basal estradiol levels were analyzed using the Mann–Whitney U test. Fertilization rate, cleavage rate, blastocyst formation rate, and good-quality blastocyst rate were analyzed using Fisher’s exact test. Infertility etiologies were compared between groups using the chi-square test.

11. Ethics statement

This study was approved by the Ethics Committee of Kyoto University Hospital (approval number: R3512), and was conducted in accordance with institutional ethical guidelines.

Results

Before installation of the VOC-removal filter, the VOC concentration in the embryology laboratory was 38 µg/m³. Ethanol, toluene, ethylbenzene, and other compounds were detected. After installation of the VOC-removal filter, the VOC concentration markedly decreased to 0.8 µg/m³ (Table 2).

Changes in volatile organic compound (VOC) concentrations (µg/m³) before and after installation of VOC-removal filters

The effects of VOC-removal filter installation on embryo development were then evaluated. The number of oocyte retrieval cycles was 193 in the pre-installation group and 86 in the post-installation group. Mean maternal age at oocyte retrieval was similar between groups: 39.32 years in the pre-installation group and 39.29 years in the post-installation group (p=0.9408). Most baseline characteristics did not differ significantly between groups, although basal estradiol levels differed in the overall analysis (Table 1). The numbers of morphologically normal oocytes included in the analysis were 1,044 in the pre-installation group and 581 in the post-installation group. Fertilization rate was significantly higher in the pre-installation group than in the post-installation group (77.1% vs. 72.1%, p=0.0265). Cleavage rate was 74.8% in the pre-installation group and 71.4% in the post-installation group (p=0.1425). Blastocyst formation rate was 20.1% in the pre-installation group and 17.4% in the post-installation group (p=0.1886). Good-quality blastocyst rate was 7.3% in the pre-installation group and 9.5% in the post-installation group (p=0.1286). Thus, no significant differences were observed between groups in cleavage rate, blastocyst formation rate, or good-quality blastocyst rate (Table 3).

Comparison of clinical and embryological outcomes before and after volatile organic compound filter installation

Subgroup analyses were performed separately for IVF and ICSI cycles before and after installation of the VOC-removal filter. Among IVF cycles, the number of oocyte retrieval cycles was 43 in the pre-installation group and 20 in the post-installation group. Mean maternal age was 37.37 years in the pre-installation group and 37.05 years in the post-installation group, with no significant difference between groups (p=0.8401). The numbers of morphologically normal oocytes included in the analysis were 396 in the pre-installation group and 152 in the post-installation group. Fertilization rate was 73.0% in the pre-installation group and 64.5% in the post-installation group (p=0.0592). Cleavage rate was 71.2% in the pre-installation group and 63.2% in the post-installation group (p=0.0794). Blastocyst formation rate was 22.0% in the pre-installation group and 20.4% in the post-installation group (p=0.7288). Good-quality blastocyst rate was 11.6% in the pre-installation group and 11.2% in the post-installation group (p=1.0000). No significant differences were observed between groups in fertilization rate, cleavage rate, blastocyst formation rate, or good-quality blastocyst rate among IVF cycles (Table 4).

Comparison of in vitro fertilization outcomes before and after volatile organic compound filter installation

Among ICSI cycles, the number of oocyte retrieval cycles was 150 in the pre-installation group and 66 in the post-installation group. Mean maternal age was 39.88 years in the pre-installation group and 39.97 years in the post-installation group, with no significant difference between groups (p=0.8826). The numbers of morphologically normal oocytes included in the analysis were 648 in the pre-installation group and 429 in the post-installation group. Fertilization rate was 79.6% in the pre-installation group and 74.8% in the post-installation group (p=0.0726). Cleavage rate was 77.0% in the pre-installation group and 74.4% in the post-installation group (p=0.3439). Blastocyst formation rate was 19.0% in the pre-installation group and 16.3% in the post-installation group (p=0.2916). In contrast, good-quality blastocyst rate was significantly higher in the post-installation group than in the pre-installation group (8.9% vs. 4.6%, p=0.0069) (Table 5).

Comparison of intracytoplasmic sperm injection outcomes before and after volatile organic compound filter installation

Although fertilization rate, cleavage rate, and blastocyst formation rate did not differ significantly between groups among ICSI cycles, the proportion of good-quality blastocysts was significantly higher in the post-installation group. Despite the lower overall fertilization rate after filter installation, the post-installation group yielded a higher proportion of transferable good-quality blastocysts derived from morphologically normal oocytes.

Discussion

This study showed that VOC removal in the clinical embryology laboratory was associated with improved blastocyst quality in ICSI cycles. Obtaining more good-quality blastocysts in ART requires careful control of the culture environment, including culture media, temperature, light exposure, and air quality. With respect to air quality, many facilities use positive-pressure ventilation systems and high-efficiency particulate air (HEPA) filters to prevent the inflow of external contaminants such as pollen and particulate matter ≤2.5 µm in diameter. However, contaminants generated within the embryology laboratory itself also require attention. These internal sources include building materials, plastic products used in embryo culture, and disinfectants such as ethanol.

Before filter installation, the VOCs detected in the clinical embryology laboratory were primarily ethanol, toluene, and ethylbenzene. Ethanol is mainly used for hand hygiene and for disinfecting laboratory equipment, including clean benches. By contrast, toluene and ethylbenzene are components of building materials and were presumed to have entered the laboratory through contamination from the shared hospital heating, ventilation, and air conditioning system.

After installation of the VOC-removal filter, VOC concentrations in the laboratory environment decreased substantially. The VOC filter was operated within its calculated lifetime, which was determined on the basis of room volume and the initial VOC concentration. The filter also retained adequate remaining capacity at the end of the study. Filtration efficiency was therefore considered to have been maintained throughout the intervention period. Previous studies have reported that VOCs such as toluene and formaldehyde can induce mitochondrial dysfunction and increase DNA fragmentation through oxidative DNA damage [15-22]. Elevated VOC concentrations have also been associated with delayed embryo development and reduced cell numbers in the TE layer [23].

In the overall analysis, fertilization rate was significantly higher in the pre-installation group than in the post-installation group (77.1% vs. 72.1%). This finding differs from previous reports suggesting that reduced VOC exposure either improves fertilization rates or has no measurable effect [3,24,25]. Fertilization can be influenced by oocyte quality, sperm quality, and the culture environment [26-29]. Other environmental factors, including culture media, temperature, and light exposure, were not changed between the pre-installation and post-installation periods [30-34]. Mean maternal age also did not differ between the two periods, suggesting that major age-related differences in oocyte quality were unlikely. Although basal estradiol levels differed significantly in the overall analysis, values in both groups remained within the physiological range, suggesting limited clinical impact on the overall outcomes. The reason for the higher fertilization rate in the pre-installation group therefore could not be clearly identified. By contrast, among ICSI cycles, the good-quality blastocyst rate based on the Gardner classification was significantly higher after VOC-removal filter installation. This finding is clinically relevant because it indicates a higher proportion of transferable embryos. The improvement may reflect reduced VOC-related impairment of cell division, which may increase total blastocyst cell number, including the TE cell population, and thereby contribute to improved blastocyst quality [23].

The absence of significant differences among IVF cycles may be partly explained by the shorter laboratory handling time required for IVF than for ICSI. In IVF cycles, handling is limited primarily to insemination and fertilization assessment. In addition, during the 16 to 18 hours between insemination and fertilization assessment, oocytes remain surrounded by COCs, which may protect gametes from VOC-induced damage [35]. ICSI, by contrast, requires several handling steps, including denudation, assessment of oocyte maturity, and micromanipulation, which prolong laboratory exposure. The substantial reduction in VOC concentrations achieved by filter installation may therefore have reduced VOC-related damage to gametes and embryos during ICSI procedures. This reduction may have contributed to the higher good-quality blastocyst rate observed among ICSI cycles, as assessed using the Gardner classification, which reflects both ICM and TE cell numbers [23,36].

Taken together, these findings suggest that VOC removal in the clinical embryology laboratory may improve blastocyst quality, particularly in ICSI cycles, in which laboratory handling time is relatively prolonged. VOC control may therefore contribute to improved ART outcomes, including pregnancy rates [37,38].

This study has several limitations. First, it was a single-center, before–after observational study; therefore, temporal confounding cannot be entirely excluded. In addition, practical constraints related to the limited loan period of the VOC-removal filter resulted in unequal sample sizes between the pre-installation and post-installation groups. Second, VOC concentrations inside incubators were not directly measured or controlled. Previous studies have indicated that VOCs can be emitted from CO₂ and N₂ gas cylinders and from plastic products, including culture dishes, and may be detectable within incubator environments [4,35,39]. Future studies should examine the relationship between incubator VOC concentrations and fertilization rates, blastocyst development, and embryo quality to clarify the effects of VOC exposure on embryo development.

In conclusion, comprehensive air-quality management in the clinical embryology laboratory should include not only positive-pressure ventilation and HEPA filtration to prevent external contamination, but also control of VOC concentrations. This broader approach to air-quality management may help improve the embryo culture environment and support better embryo quality.

Notes

Conflict of interest

This study was conducted under a joint research agreement with Daikin Industries, Ltd., and was supported by research funding from the company. The authors declare no other potential conflicts of interest.

Acknowledgments

This study was presented as an oral presentation at the 65th Annual Meeting of the Japan Society for Ova Research, held May 18–19, 2024, Kobe, Japan.

The authors sincerely thank Daikin Industries, Ltd., for their collaboration and support.

Author contributions

Conceptualization: KS, YS, AH. Methodology: KS, YS, YK, AO. Formal analysis: KS, YS, YK, AO. Data curation: KS, MI, SS. Supervision: MM. Writing-original draft: KS, YS. Writing-review & editing: KS, YS, MM. Approval of final manuscript: KS, YS, MI, SS, YK, AO, MM, AH.

Supplementary materials

Supplementary material can be found via https://doi.org/10.5653/cerm.2026.09369.

Supplementary Table 1.

Infertility etiologies in the overall cohort, IVF cycle, and ICSI cycle

cerm-2026-09369-Supplementary-Table-1.pdf

References

1. Murugappan G, Kim JG, Kort JD, Hanson BM, Neal SA, Tiegs AW, et al. Prognostic value of blastocyst grade after frozen euploid embryo transfer in patients with recurrent pregnancy loss. F S Rep 2020;1:113–8. 10.1016/j.xfre.2020.07.001. 33817669.
2. Ahlstrom A, Westin C, Wikland M, Hardarson T. Prediction of live birth in frozen–thawed single blastocyst transfer cycles by pre-freeze and post-thaw morphology. Hum Reprod 2013;28:1199–209. 10.1093/humrep/det054. 23477908.
3. Boone WR, Johnson JE, Locke AJ, Crane MM, Price TM. Control of air quality in an assisted reproductive technology laboratory. Fertil Steril 1999;71:150–4. 10.1016/s0015-0282(98)00395-1. 9935133.
4. Cohen J, Gilligan A, Esposito W, Schimmel T, Dale B. Ambient air and its potential effects on conception in vitro. Hum Reprod 1997;12:1742–9. 10.1093/humrep/12.8.1742. 9308805.
5. Esteves SC, Gomes AP, Verza S Jr. Control of air pollution in assisted reproductive technology laboratory and adjacent areas improves embryo formation, cleavage and pregnancy rates and decreases abortion rate: comparison between a class 100 (ISO 5) and a class 1,000 (ISO 6) cleanroom for micromanipulation and embryo culture. Fertil Steril 2004;82(Suppl 2):S259–60. 10.1016/j.fertnstert.2004.07.691.
6. Hall J, Gilligan A, Schimmel T, Cecchi M, Cohen J. The origin, effects and control of air pollution in laboratories used for human embryo culture. Hum Reprod 1998;13 Suppl 4:146–55. 10.1093/humrep/13.suppl_4.146. 10091065.
7. Little SA, Mirkes PE. Relationship of DNA damage and embryotoxicity induced by 4-hydroperoxydechlorocyclophosphamide in postimplantation rat embryos. Teratology 1990;41:223–31. 10.1002/tera.1420410214. 2321166.
8. Mayer JF, Nehchiri F, Weedon VM, Jones EL, Kalin HL, Oehninger SC, et al. Prospective randomized crossover analysis of the impact of an IVF incubator air filtration system (Coda, GenX) on clinical pregnancy rates. Fertil Steril 1999;72(3 Suppl 1):S42.
9. Worrilow KC, Huynh HT, Bower JB, Schillings W, Peters AJ. A retrospective analysis: seasonal decline in implantation rates (IR) and its correlation with increased levels of volatile organic compounds (VOC). Fertil Steril 2002;78(Suppl 1):S39. 10.1016/s0015-0282(02)03482-9.
10. Sciorio R, Rapalini E, Esteves SC. Air quality in the clinical embryology laboratory: a mini-review. Ther Adv Reprod Health 2021;15:2633494121990684. 10.1177/2633494121990684. 33629068.
11. Khoudja RY, Xu Y, Li T, Zhou C. Better IVF outcomes following improvements in laboratory air quality. J Assist Reprod Genet 2013;30:69–76. 10.1007/s10815-012-9900-1. 23242648.
12. Dadvand P, Rankin J, Rushton S, Pless-Mulloli T. Association between maternal exposure to ambient air pollution and congenital heart disease: a register-based spatiotemporal analysis. Am J Epidemiol 2011;173:171–82. 10.1093/aje/kwq342. 21123851.
13. Rubes J, Selevan SG, Evenson DP, Zudova D, Vozdova M, Zudova Z, et al. Episodic air pollution is associated with increased DNA fragmentation in human sperm without other changes in semen quality. Hum Reprod 2005;20:2776–83. 10.1093/humrep/dei122. 15980006.
14. Gardner DK, Lane M, Stevens J, Schlenker T, Schoolcraft WB. Blastocyst score affects implantation and pregnancy outcome: towards a single blastocyst transfer. Fertil Steril 2000;73:1155–8. 10.1016/s0015-0282(00)00518-5. 10856474.
15. Gardner DK, Lane M. Alleviation of the ‘2-cell block’ and development to the blastocyst of CF1 mouse embryos: role of amino acids, EDTA and physical parameters. Hum Reprod 1996;11:2703–12. 9021376.
16. Hang B, Sarker AH, Havel C, Saha S, Hazra TK, Schick S, et al. Thirdhand smoke causes DNA damage in human cells. Mutagenesis 2013;28:381–91. 10.1093/mutage/get013. 23462851.
17. McDermott C, Allshire A, van Pelt FN, Heffron JJ. Sub-chronic toxicity of low concentrations of industrial volatile organic pollutants in vitro. Toxicol Appl Pharmacol 2007;219:85–94. 10.1016/j.taap.2006.12.004. 17239415.
18. Munch EM, Sparks AE, Duran HE, Van Voorhis BJ. Lack of carbon air filtration impacts early embryo development. J Assist Reprod Genet 2015;32:1009–17. 10.1007/s10815-015-0495-1. 26003657.
19. Pariselli F, Sacco MG, Rembges D. An optimized method for in vitro exposure of human-derived lung cells to volatile chemicals. Exp Toxicol Pathol 2009;61:33–9. 10.1016/j.etp.2008.05.008. 18650076.
20. Rieger D. Culture systems: physiological and environmental factors that can affect the outcome of human ART. Methods Mol Biol 2012;912:333–54. 10.1007/978-1-61779-971-6_19. 22829383.
21. Simopoulou M, Sfakianoudis K, Rapani A, Giannelou P, Anifandis G, Bolaris S, et al. Considerations regarding embryo culture conditions: from media to epigenetics. In Vivo 2018;32:451–60. 29695546.
22. Velker BA, Denomme MM, Mann MR. Embryo culture and epigenetics. Methods Mol Biol 2012;912:399–421. 10.1007/978-1-61779-971-6_23. 22829387.
23. Cai J, Zhou L, Liu L, Liu Z, Chen J, Chen K, et al. Real-time monitoring reveals the effects of low concentrations of volatile organic compounds in the embryology laboratory. Hum Reprod 2025;40:601–11. 10.1093/humrep/deaf008. 39999401.
24. Higdon HL, Blackhurst DW, Boone WR. Incubator management in an assisted reproductive technology laboratory. Fertil Steril 2008;89:703–10. 10.1016/j.fertnstert.2007.03.040. 17524397.
25. Palmer GA, Kratka C, Szvetecz S, Fiser G, Fiser S, Sanders C, et al. Comparison of 36 assisted reproduction laboratories monitoring environmental conditions and instrument parameters using the same quality-control application. Reprod Biomed Online 2019;39:63–74. 10.1016/j.rbmo.2019.03.204. 31126717.
26. Iljas JD, Wei Z, Homer HA. Sirt1 sustains female fertility by slowing age-related decline in oocyte quality required for post-fertilization embryo development. Aging Cell 2020;19e13204. 10.1111/acel.13204. 32729989.
27. Wang L, Tang J, Wang L, Tan F, Song H, Zhou J, et al. Oxidative stress in oocyte aging and female reproduction. J Cell Physiol 2021;236:7966–83. 10.1002/jcp.30468. 34121193.
28. Lopes S, Jurisicova A, Sun JG, Casper RF. Reactive oxygen species: potential cause for DNA fragmentation in human spermatozoa. Hum Reprod 1998;13:896–900. 10.1093/humrep/13.4.896. 9619544.
29. Simon L, Brunborg G, Stevenson M, Lutton D, McManus J, Lewis SE. Clinical significance of sperm DNA damage in assisted reproduction outcome. Hum Reprod 2010;25:1594–608. 10.1093/humrep/deq103. 20447937.
30. Fawzy M, Emad M, Gad MA, Sabry M, Kasem H, Mahmoud M, et al. Comparing 36.5°C with 37°C for human embryo culture: a prospective randomized controlled trial. Reprod Biomed Online 2018;36:620–6. 10.1016/j.rbmo.2018.03.011. 29625822.
31. Swearman H, Koustas G, Knight E, Liperis G, Grupen C, Sjoblom C. pH: the silent variable significantly impacting meiotic spindle assembly in mouse oocytes. Reprod Biomed Online 2018;37:279–90. 10.1016/j.rbmo.2018.06.022. 30314883.
32. Baltz JM, Zhou C. Cell volume regulation in mammalian oocytes and preimplantation embryos. Mol Reprod Dev 2012;79:821–31. 10.1002/mrd.22117. 23011956.
33. Nakayama T, Noda Y, Goto Y, Mori T. Effects of visible light and other environmental factors on the production of oxygen radicals by hamster embryos. Theriogenology 1994;41:499–510. 10.1016/0093-691x(94)90086-x. 16727408.
34. Pomeroy KO, Reed ML. The effect of light on embryos and embryo culture. J Reprod Stem Cell Biotechnol 2012;3:46–54. 10.1177/205891581200300203.
35. Fox JT, Ni P, Urrutia AR, Huynh HT, Worrilow KC. Modelling the equilibrium partitioning of low concentrations of airborne volatile organic compounds in human IVF laboratories. Reprod Biomed Online 2023;46:54–68. 10.1016/j.rbmo.2022.05.006. 36372658.
36. Meng ZQ, Zhang LZ. Chromosomal aberrations and sister chromatid exchanges in lymphocytes of workers exposed to sulfur dioxide. Mutat Res 1990;241:15–20. 2333082.
37. Agarwal N, Chattopadhyay R, Ghosh S, Bhoumik A, Goswami SK, Chakravarty B. Volatile organic compounds and good laboratory practices in the in vitro fertilization laboratory: the important parameters for successful outcome in extended culture. J Assist Reprod Genet 2017;34:999–1006. 10.1007/s10815-017-0947-x. 28540437.
38. Zhao YY, Yu Y, Zhang XW. Overall blastocyst quality, trophectoderm grade, and inner cell mass grade predict pregnancy outcome in euploid blastocyst transfer cycles. Chin Med J (Engl) 2018;131:1261–7. 10.4103/0366-6999.232808. 29786036.
39. Merton JS, Vermeulen ZL, Otter T, Mullaart E, de Ruigh L, Hasler JF. Carbon-activated gas filtration in vitro culture increased pregnancy rate following transfer of in vitro-produced bovine embryos. Theriogenology 2007;67:1233–8. 10.1016/j.theriogenology.2006.12.012. 17331571.

Article information Continued

Table 1.

Baseline patient characteristics in the overall analysis, IVF cycle, and ICSI cycle

Parameter Pre-installation group Post-installation group p-value
Overall analysis
 OPU cycles 193 86 -
 Patient age (yr) 39.32±0.29 39.29±0.50 0.941
 BMI (kg/m²) 21.89 (19.41–24.52) 21.42 (19.33–23.36) 0.155
 AFC 4 (2–7) 4 (2–7) 0.749
 Basal FSH (mIU/mL) 8.7 (6.5–12.4) 9.7 (7.9–13.8) 0.107
 Basal E2 (pg/mL) 32.4 (20.2–51.5) 28.7 (17.2–44.8) 0.041a)
IVF cycles
 OPU cycles 43 20 -
 Patient age (yr) 37.37±0.57 37.05±1.02 0.840
 BMI (kg/m²) 22.37 (19.33–24.52) 22.05 (19.45–22.57) 0.337
 AFC 7 (4–9) 6.5 (2–8.75) 0.310
 Basal FSH (mIU/mL) 7.4 (5.5–10.4) 9.6 (7.8–11.0) 0.138
 Basal E2 (pg/mL) 30.1 (22.4–44.3) 23.9 (14.5–46.5) 0.291
ICSI cycles
 OPU cycles 150 66 -
 Patient age (yr) 39.88±0.32 39.97±0.55 0.883
 BMI (kg/m²) 21.89 (19.43–24.33) 20.7 (19.33–24.41) 0.261
 AFC 4 (2–6) 4 (2–6) 0.691
 Basal FSH (mIU/mL) 9.1 (7.1–13.4) 9.9 (7.9–15.2) 0.197
 Basal E2 (pg/mL) 33.5 (20.0–54.7) 29.1 (19.3–44.8) 0.078

Values are presented as mean±standard deviation or median (interquartile range).

IVF, in vitro fertilization; ICSI, intracytoplasmic sperm injection; VOC, volatile organic compound; OPU, ovum pick-up; BMI, body mass index; AFC, antral follicle count; FSH, follicle-stimulating hormone; E2, estradiol.

a)

Statistically significant (p<0.05).

Table 2.

Changes in volatile organic compound (VOC) concentrations (µg/m³) before and after installation of VOC-removal filters

Variable Before After
Total 38 0.8
Ethanol 1.1 0
Toluene 5.6 0.7
Ethylbenzene 2.2 0
1,2-dichlorobenzene 1.9 0
Benzoic acid 1.9 0
Siloxane (D5) 1.7 0

Table 3.

Comparison of clinical and embryological outcomes before and after volatile organic compound filter installation

Parameter Pre-installation group Post-installation group OR (95% CI) p-value
OPU cycles 193 86
Morphologically normal oocytes 1,044 581
Fertilization rate (%) 77.1 (805/1,044) 72.1 (419/581) 0.77 (0.61–0.97) 0.0265a)
Cleavage rate (%) 74.8 (781/1,044) 71.4 (415/581) 0.84 (0.67–1.06) 0.1425
Blastocyst rate (%) 20.1 (210/1,044) 17.4 (101/581) 0.84 (0.64–1.09) 0.1886
Good-quality blastocyst rate (%) 7.3 (76/1,044) 9.5 (55/581) 1.33 (0.93–1.92) 0.1286

Values are presented as percentage (number/total number).

VOC, volatile organic compound; OR, odds ratio; CI, confidence interval; OPU, ovum pick-up.

a)

Statistically significant (p<0.05).

Table 4.

Comparison of in vitro fertilization outcomes before and after volatile organic compound filter installation

Parameter Pre-installation group Post-installation group OR (95% CI) p-value
OPU cycles 43 20
Morphologically normal oocytes 396 152
Fertilization rate (%) 73.0 (289/396) 64.5 (98/152) 0.67 (0.45–1.00) 0.0592
Cleavage rate (%) 71.2 (282/396) 63.2 (96/152) 0.69 (0.47–1.03) 0.0794
Blastocyst rate (%) 22.0 (87/396) 20.4 (31/152) 0.91 (0.57–1.44) 0.7288
Good-quality blastocyst rate (%) 11.6 (46/396) 11.2 (17/152) 0.96 (0.53–1.73) 1.0000

Values are presented as percentage (number/total number).

VOC, volatile organic compound; OR, odds ratio; CI, confidence interval; OPU, ovum pick-up.

Table 5.

Comparison of intracytoplasmic sperm injection outcomes before and after volatile organic compound filter installation

Parameter Pre-installation group Post-installation group OR (95% CI) p-value
OPU cycles 150 66
Morphologically normal oocytes 648 429
Fertilization rate (%) 79.6 (516/648) 74.8 (321/429) 0.76 (0.57–1.02) 0.0726
Cleavage rate (%) 77.0 (499/648) 74.4 (319/429) 0.87 (0.65–1.15) 0.3439
Blastocyst rate (%) 19.0 (123/648) 16.3 (70/429) 0.83 (0.60–1.15) 0.2916
Good-quality blastocyst rate (%) 4.6 (30/648) 8.9 (38/429) 2.00 (1.22–3.29) 0.0069a)

Values are presented as percentage (number/total number).

VOC, volatile organic compound; OR, odds ratio; CI, confidence interval; OPU, ovum pick-up.

a)

Statistically significant (p<0.05).